Mikhail Blagosklonny holds a position as the chief editor of Cell Cycle and Oncotarget. He is an associate of other publications that focus on the treatment of cancer. He is known for his skills in therapy and biology of cancer. Nature.com reported that Mikhail Blagosklonny is also on the editorial board of Cell Death and Differentiation.
He is popular for his hypothesis in TOR which seeks to explore the relationship between cancer and aging. He has reportedly used Rapamycin to a carry out his research. Rapamycin is a popular drug used to treat cancer. Mikhail has shown a considerable zeal and approach to finding the latest approach to cancer therapy.
The longevity of cancer treatment research has seen him become labeled as one of the most passionate advocates of the Rapamycin research. His research varies from molecular biology, cellular biology to several clinical investigations. He has researched in other sections such as drug resistance of healthy cells, tumor suppressors, cell cycle, and anticancer therapeutics.
Mikhail Blagosklonny has a thorough understanding of the field of medicine. He earned his Medical Doctorate in the field of internal medicine. He later received a Ph.D. in the area of cardiology and medicine. He was able to attend the Russian Medical University and the First Pavlov Medical University.
Mikhail Blagosklonny’s experience in cancer research saw him become appointed as an associate professor of medicine at the New York Medical School. He held this position for some time in the year 2002 before earning a position as Senior Scientist at the Ordway Research Institute in Albany, New York.
Mikhail Blagosklonny was able to hold this position until 2009 before he became appointed as Professor of Oncology at the Roswell Park Institute of Cancer.
According to Research Gate, Mikhail Blagosklonny has focused his research in the field of cancer and its therapies that protect cells from getting damaged. He is famous for his studies in the area of aging and coming up with anti-aging drugs.
During his research, he was able to hypothesize the working of the Rapamycin enzyme. The enzyme is popularly acclaimed for its positive effects in cancer treatment. He was able to see how the drug prolonged the lives of cells and therefore prevented aging.